Werring received his Bachelor in Neurosciences in 1989 and his Bachelor in Medicine/Bachelor in Surgery from Guy's Hospital Medical School in 1992. He became a Member of the Royal Colleges of Physicians of the United Kingdom (MRCP) in 1995 and finished his PhD in clinical neurology at the UCL Queen Square Institute of Neurology in 2000.[1] After completing his clinical training in neurology and stroke medicine in 2004, he was appointed consultant neurologist at the National Hospital for Neurology and Neurosurgery, University College Hospital and Watford General Hospital in 2005.[2] Werring was made Reader in clinical neurology and honorary consultant neurologist in 2008, became a fellow of the Royal College of Physicians (FRCP) in 2012 and was made full professor at UCL Queen Square Institute of Neurology in 2015. In 2017, he became head of the research department of Brain Repair & Rehabilitation at the UCL Queen Square Institute of Neurology.[2] The name of this department changed to the Department of Translational Neuroscience and Stroke in 2025.
Werring is a recognized expert in the field of stroke, chaired the UK Stroke Forum 2020-2022 and is President of the British and Irish Association of Stroke Physicians since December 2023.[3][4] He was elected as a Life Member, Clare Hall, University of Cambridge,[5] in 2023. He was appointed as a National Institute of Health Research (NIHR) Senior Investigator in 2024.[6] He was elected to the Academy of Medical Sciences in 2025.[7]
Scientific expertise
The core field of research of Werring is stroke, in particular cerebral small vessel disease, intracerebral hemorrhage and cerebral amyloid angiopathy.[2] He has published more than 490 peer-reviewed articles on those topics and in other fields of clinical neurology.[2] Werring has led large collaborative studies investigating cerebral microbleeds and has expertise in neuroimaging, with a focus on brain MRI.[1] He was the Chief Investigator of a large multi-centre study investigating the timing of oral anticoagulation after ischemic stroke, OPTIMAS,[8] funded by the British Heart Foundation[9] and has been involved in several studies investigating the influence of COVID-19 and respective vaccines on stroke.[10] He has an h-index of 108,[11] and is an editor of the Queen Square textbook of Neurology. He is an editorial board member of several scientific journals, including the European Stroke Journal, International Journal of Stroke, and the European Journal of Neurology.[12][13][14]
This page is based on this Wikipedia article Text is available under the CC BY-SA 4.0 license; additional terms may apply. Images, videos and audio are available under their respective licenses.
